EP 1032708 A4 20040915 - NUCLEIC ACID LIGANDS OF TISSUE TARGET
Title (en)
NUCLEIC ACID LIGANDS OF TISSUE TARGET
Title (de)
NUKLEINSÄURELIGANDEN FÜR ZIELGEWEBE
Title (fr)
LIGANDS D'ACIDE NUCLEIQUE DE CIBLE TISSULAIRE
Publication
Application
Priority
- US 9825006 W 19981119
- US 97641397 A 19971121
Abstract (en)
[origin: WO9927138A1] This invention discloses high-affinity oligonucleotide ligands to complex tissue targets, specifically nucleic acid ligands having the ability to bind to complex tissue targets, and the methods for obtaining such ligands. Tissue targets comprise cells, subcellular components, aggregates or cells, collections of cells, and higher ordered structures. Specifically, nucleic acid ligands to blood vessels are described.
IPC 1-7
IPC 8 full level
C12N 15/09 (2006.01); C07H 19/06 (2006.01); C07H 19/10 (2006.01); C07H 21/00 (2006.01); C07H 23/00 (2006.01); C07K 7/22 (2006.01); C07K 14/00 (2006.01); C07K 14/16 (2006.01); C07K 14/72 (2006.01); C12N 9/12 (2006.01); C12N 15/10 (2006.01); C12N 15/115 (2010.01); C12Q 1/37 (2006.01); C12Q 1/68 (2006.01); C12Q 1/70 (2006.01); G01N 33/53 (2006.01); G01N 33/531 (2006.01); G01N 33/532 (2006.01); G01N 33/535 (2006.01); G01N 33/569 (2006.01); G01N 33/68 (2006.01); G01N 33/76 (2006.01); A61K 38/00 (2006.01); C07B 61/00 (2006.01); F02B 75/02 (2006.01)
CPC (source: EP US)
A61K 47/547 (2017.07 - EP US); A61K 47/549 (2017.07 - EP US); B82Y 5/00 (2013.01 - EP US); C07H 19/06 (2013.01 - EP US); C07H 19/10 (2013.01 - EP US); C07H 21/00 (2013.01 - EP US); C07K 7/22 (2013.01 - EP US); C07K 14/001 (2013.01 - EP US); C07K 14/005 (2013.01 - EP US); C07K 14/72 (2013.01 - EP US); C12N 9/1276 (2013.01 - EP US); C12N 15/1048 (2013.01 - EP US); C12N 15/115 (2013.01 - EP US); C12Q 1/37 (2013.01 - EP US); G01N 33/53 (2013.01 - EP US); G01N 33/531 (2013.01 - EP US); G01N 33/532 (2013.01 - EP US); G01N 33/535 (2013.01 - EP US); G01N 33/56988 (2013.01 - EP US); G01N 33/68 (2013.01 - EP US); G01N 33/76 (2013.01 - EP US); A61K 38/00 (2013.01 - EP US); C12N 2310/13 (2013.01 - EP US); C12N 2310/16 (2013.01 - EP US); C12N 2310/321 (2013.01 - EP US); C12N 2310/322 (2013.01 - EP US); C12N 2310/344 (2013.01 - EP US); C12N 2310/53 (2013.01 - EP US); C12N 2740/16222 (2013.01 - EP US); C40B 40/00 (2013.01 - EP US); F02B 2075/027 (2013.01 - EP US); G01N 2333/16 (2013.01 - EP US); G01N 2333/163 (2013.01 - EP US); G01N 2333/4724 (2013.01 - EP US); G01N 2333/503 (2013.01 - EP US); G01N 2333/575 (2013.01 - EP US); G01N 2333/62 (2013.01 - EP US); G01N 2333/7056 (2013.01 - EP US); G01N 2333/8125 (2013.01 - EP US); G01N 2333/96433 (2013.01 - EP US); G01N 2333/96436 (2013.01 - EP US); G01N 2333/96455 (2013.01 - EP US); G01N 2333/96486 (2013.01 - EP US); G01N 2333/966 (2013.01 - EP US); G01N 2333/9726 (2013.01 - EP US); G01N 2333/974 (2013.01 - EP US); G01N 2333/976 (2013.01 - EP US)
Citation (search report)
- [X] WO 9634874 A1 19961107 - NEXSTAR PHARMACEUTICALS INC [US], et al
- [A] JELLINEK D ET AL: "INHIBITION OF RECEPTOR BINDING BY HIGH-AFFINITY RNA LIGANDS TO VASCULAR ENDOTHELIAL GROWTH FACTOR", BIOCHEMISTRY, AMERICAN CHEMICAL SOCIETY. EASTON, PA, US, vol. 34, no. 33, 30 August 1994 (1994-08-30), pages 10450 - 10456, XP001084739, ISSN: 0006-2960
- See references of WO 9927138A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9927138 A1 19990603; AU 1600499 A 19990615; AU 750820 B2 20020725; CA 2311164 A1 19990603; EP 1032708 A1 20000906; EP 1032708 A4 20040915; JP 2001524320 A 20011204; US 6127119 A 20001003
DOCDB simple family (application)
US 9825006 W 19981119; AU 1600499 A 19981119; CA 2311164 A 19981119; EP 98960403 A 19981119; JP 2000522279 A 19981119; US 97641397 A 19971121